Acute Myeloid Leukemia	NCCN Acute Myeloid Leukemia Cancer Panel Members	NCCN Acute Myeloid Leukemia Cancer Guideline
Anal Carcinoma	NCCN Anal Carcinoma Panel Members	NCCN Anal Carcinoma Guideline
Bladder Cancer Bladder Cancer Upper GU Tract Tumors Urothelial Carcinoma of the Prostate	NCCN Bladder Cancer Panel Members	NCCN Bladder Cancer Guideline
Bone Cancer Ewing�s Sarcoma Osteosarcoma	NCCN Bone Cancer Panel Members	NCCN Bone Cancer Guideline
Breast Cancer Breast Cancer, Noninvasive Breast Cancer, Invasive Paget’s Disease Breast Cancer During Pregnancy	NCCN Breast Cancer Panel Members	NCCN Breast Cancer Guideline
Central Nervous System Cancers Metastatic Central Nervous System Lesions Primary Central Nervous System Tumors	NCCN Central Nervous System Cancers Panel Members	NCCN Central Nervous System Cancers Guideline
Cervical Cancer	NCCN Cervical Cancer Panel Members	NCCN Cervical Cancer Guideline
Chronic Myelogenous Leukemia	NCCN Chronic Myelogenous Leukemia Cancer Panel Members	NCCN Chronic Myelogenous Leukemia Cancer Guideline
Colon Cancer	NCCN Colon Cancer Panel Members	NCCN Colon Cancer Guideline
Esophageal Cancer	NCCN Esophageal Cancer Panel Members	NCCN Esophageal Cancer Guideline
Gastric Cancer	NCCN Gastric Cancer Panel Members	NCCN Gastric Cancer Guideline
Head and Neck Cancers Ethmoid Sinus Tumors Maxillary Sinus Tumors Cancer of the Lip Cancer of the Oral Cavity Cancer of the Oropharynx Cancer of the Hypopharynx Occult Primary Cancer of the Glottic Larynx Cancer of the Supraglottic Larynx Cancer of the Nasopharynx Unresectable and Recurrent Head and Neck Cancers	NCCN Head and Neck Cancers Panel Members	NCCN Head and Neck Cancers Guideline
Hepatobiliary Cancers Hepatocellular Carcinoma Gallbladder Cancer Intrahepatic Cholangiocarcinoma Extrahepatic Cholangiocarcinoma	NCCN Hepatobiliary Cancers Panel Members	NCCN Hepatobiliary Cancers Guideline
Hodgkin Disease/Lymphoma Classical Hodgkin Lymphoma Lymphocyte-predominant Hodgkin Lymphoma	NCCN Hodgkin Disease/Lymphoma Cancer Panel Members	NCCN Hodgkin Disease/Lymphoma Cancer Guideline
Kidney Cancer	NCCN Kidney Cancer Panel Members	NCCN Kidney Cancer Guideline
Melanoma	NCCN Melanoma Panel Members	NCCN Melanoma Guideline
Multiple Myeloma Multiple Myeloma Systemic Light Chain Amyloidosis Waldenstr�m�s Macroglobulinemia	NCCN Multiple Myeloma Panel Members	NCCN Multiple Myeloma Guideline
Myelodysplastic Syndromes	NCCN Myelodysplastic Syndromes Panel Members	NCCN Myelodysplastic Syndromes Guideline
Neuroendocrine Tumors Carcinoid Tumors Islet Cell Tumors Adrenal Gland Tumors Pheochromocytoma Poorly Differentiated (Anaplastic) Multiple Endocrine Neoplasia Type 1	NCCN Neuroendocrine Tumors Panel Members	NCCN Neuroendocrine Tumors Guideline
Non-Hodgkin's Lymphoma Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Gastric MALT Lymphoma Nongastric MALT Lymphoma Splenic Marginal Zone Lymphoma Mantle Cell Lymphoma Diffuse Large B-Cell Lymphoma Burkitt's Lymphoma Lymphoblastic Lymphoma AIDS-Related B-Cell Lymphoma Peripheral T-Cell Lymphoma Mycosis Fungoides and Sezary Syndrome	NCCN Non-Hodgkin's Lymphoma Panel Members	NCCN Non-Hodgkin's Lymphoma Guideline
Non-Melanoma Skin Cancers	NCCN Non-Melanoma Skin Cancers Panel Members
Basal and Squamous Cell Skin Cancers		NCCN Basal and Squamous Cell Skin Cancers Guideline
Dermatofibrosarcoma Protuberance (DFSP)		NCCN Dermatofibrosarcoma Protuberance (DFSP) Guideline
Merkel Cell Carcinoma		NCCN Merkel Cell Carcinoma Guideline
Non-Small Cell Lung Cancer	NCCN Non-Small Cell Lung Cancer Panel Members	NCCN Non-Small Cell Lung Cancer Guideline
Occult Primary	NCCN Occult Primary Panel Members	NCCN Occult Primary Guideline
Ovarian Cancer Epithelial Ovarian Cancer/Fallopian Tube Cancer/ Primary Peritoneal Cancer Germ Cell Ovarian Stromal	NCCN Ovarian Cancer Panel Members	NCCN Ovarian Cancer Guideline
Pancreatic Adenocarcinoma	NCCN Pancreatic Adenocarcinoma Panel Members	NCCN Pancreatic Adenocarcinoma Guideline
Prostate Cancer	NCCN Prostate Cancer Panel Members	NCCN Prostate Cancer Guideline
Rectal Cancer	NCCN Rectal Cancer Panel Members	NCCN Rectal Cancer Guideline
Small Cell Lung Cancer	NCCN Small Cell Lung Cancer Panel Members	NCCN Small Cell Lung Cancer Guideline
Soft Tissue Sarcoma Soft Tissue Sarcoma of the Extremity Retroperitoneal/Intra-abdominal Gastrointestinal Stromal Tumors (GIST) Desmoid Tumors	NCCN Soft Tissue Sarcoma Panel Members	NCCN Soft Tissue Sarcoma Guideline
Testicular Cancer	NCCN Testicular Cancer Panel Members	NCCN Testicular Cancer Guideline
Thymic Malignancies	NCCN Thymic Malignancies Panel Members	NCCN Thymic Malignancies Guideline
Thyroid Carcinoma Papillary Carcinoma Follicular Carcinoma H�rthle Carcinoma Medullary Carcinoma	NCCN Thyroid Carcinoma Panel Members	NCCN Thyroid Carcinoma Guideline
Uterine Neoplasms Endometrial Carcinoma Uterine Sarcoma	NCCN Uterine Neoplasms Panel Members	NCCN Uterine Neoplasms Guideline

Compendium Chapters for Detection, Prevention, & Risk Reduction of Cancer

Breast Cancer Risk Reduction

NCCN Breast Cancer Risk Reduction Panel Members

NCCN Breast Cancer Risk Reduction Guidelines

Compendium Chapters for Supportive Care

Adult Cancer Pain	NCCN Adult Cancer Pain Panel Members	NCCN Adult Cancer Pain Guidelines
Antiemesis	NCCN Antiemesis Panel Members	NCCN Antiemesis Guidelines
Growth Factors
Cancer- and Chemotherapy-Induced Anemia	NCCN Cancer- and Chemotherapy-Induced Anemia Panel Members	NCCN Cancer- and Chemotherapy-Induced Anemia Guidelines
Myeloid Growth Factors	NCCN Myeloid Growth Factors Panel Members	NCCN Myeloid Growth Factors Guidelines
Prevention and Treatment of Cancer-Related Infections Cancer-Related Infections � Antibacterial Cancer-Related Infections � Antifungal Cancer-Related Infections � Antiviral	NCCN Prevention and Treatment of Cancer-Related Infections Panel Members	NCCN Prevention and Treatment of Cancer-Related Infections Guidelines
Venous Thromboembolic Disease	NCCN Venous Thromboembolic Disease Panel Members	NCCN Venous Thromboembolic Disease

Disclaimer

The recommendations regarding the uses and indications in the NCCN Drugs & Biologics Compendium� have been derived directly from the NCCN Clinical Practice Guidelines in Oncology� which are a statement of consensus of the authors with respect to the scientific evidence and their expert views of appropriate treatments for patients with cancer. The NCCN Compendium neither represents an all-inclusive listing of every drug and biologic nor every use and indication for Drugs & Biologics. The listing of Drugs & Biologics in the Compendium is limited in consideration to a discussion of the uses of Drugs & Biologics in cancer care. NCCN considers clinical trials participation to be appropriate care. Any clinician seeking to apply or consult the NCCN Compendium is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient's care or treatment.

To order the latest CD-ROM of the Complete Library of NCCN Clinical Practice Guidelines in Oncology™, please click here